Moisés Selman
Impact in
- Pulmonary and Respiratory Medicine top 0.01%
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Medical Imaging and Pathology Studies
- Occupational and environmental lung diseases
- Chronic Obstructive Pulmonary Disease (COPD) Research
- Neonatal Respiratory Health Research
- Pulmonary Hypertension Research and Treatments
- Physiology top 0.1%
- Sarcoidosis and Beryllium Toxicity Research
Papers in
-
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 263
- Medical Imaging and Pathology Studies 41
- Inhalation and Respiratory Drug Delivery 38
- Occupational and environmental lung diseases 34
- Pulmonary Hypertension Research and Treatments 32
- Neonatal Respiratory Health Research 31
- Chronic Obstructive Pulmonary Disease (COPD) Research 31
- Physiology 48
- Co-authors
- Annie Pardo (183 shared papers)Talmadge E. King (7 shared papers)Miguel Gaxiola (36 shared papers)Ganesh Raghu (9 shared papers)Naftali Kaminski (14 shared papers)Mayra Edith Mejía (22 shared papers)Carina Becerril (29 shared papers)Remedios Ramı́rez (33 shared papers)
- Journals
- American Journal of Respiratory and Critical Care Medicine (52 papers)CHEST Journal (30 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (23 papers)European Respiratory Journal (15 papers)American Journal of Respiratory Cell and Molecular Biology (13 papers)
- Partner nations
- MexicoUnited StatesUnited Kingdom
In The Last Decade
Moisés Selman
377 papers receiving 49.6k citations
Moisés Selman's Hit Papers
Peers
Comparison fields: 5 of 173
- Pulmonary and Respiratory Medicine 38.2k
- Physiology 7.7k
- Rheumatology 2.5k
- Cancer Research 2.0k
- Pathology and Forensic Medicine 2.2k
Countries citing papers authored by Moisés Selman
This map shows the geographic impact of Moisés Selman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moisés Selman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moisés Selman more than expected).
Fields of papers citing papers by Moisés Selman
This network shows the impact of papers produced by Moisés Selman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moisés Selman. The network helps show where Moisés Selman may publish in the future.
Co-authors
The 25 scholars most cited alongside Moisés Selman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 385 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and Management Hit paper breakdown → | 2011 | 5886 |
| 2 | Efficacy and Safety of Nintedanib in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2014 | 3564 |
| 3 | An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias Hit paper breakdown → | 2013 | 3255 |
| 4 | Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline Hit paper breakdown → | 2018 | 2999 |
| 5 | Idiopathic pulmonary fibrosis Hit paper breakdown → | 2011 | 1797 |
| 6 | Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Hit paper breakdown → | 2001 | 1533 |
| 7 | An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis: An Update of the 2011 Clinical Practice Guideline Hit paper breakdown → | 2015 | 1521 |
| 8 | Idiopathic pulmonary fibrosis Hit paper breakdown → | 2017 | 1042 |
| 9 | Acute Exacerbations of Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2007 | 932 |
| 10 | Efficacy of a Tyrosine Kinase Inhibitor in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2011 | 927 |
| 11 | An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease Hit paper breakdown → | 2012 | 845 |
| 12 | The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak Hit paper breakdown → | 2007 | 696 |
| 13 | Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis Hit paper breakdown → | 2013 | 642 |
| 14 | Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline Hit paper breakdown → | 2020 | 640 |
| 15 | Gene expression analysis reveals matrilysin as a key regulator of pulmonary fibrosis in mice and humans Hit paper breakdown → | 2002 | 551 |
| 16 | Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2007 | 493 |
| 17 | MMP1 and MMP7 as Potential Peripheral Blood Biomarkers in Idiopathic Pulmonary Fibrosis Hit paper breakdown → | 2008 | 488 |
| 18 | 2003 | 465 | |
| 19 | Idiopathic Nonspecific Interstitial Pneumonia Hit paper breakdown → | 2008 | 458 |
| 20 | Role of Epithelial Cells in Idiopathic Pulmonary Fibrosis: From Innocent Targets to Serial Killers Hit paper breakdown → | 2006 | 443 |
About Moisés Selman
Moisés Selman is a scholar working on Pulmonary and Respiratory Medicine, Physiology, Cancer Research, Public Health, Environmental and Occupational Health and Immunology, having authored 385 papers that have together received 51.3k indexed citations. Recurring topics across this work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (263 papers), Medical Imaging and Pathology Studies (41 papers), Inhalation and Respiratory Drug Delivery (38 papers), Occupational exposure and asthma (36 papers), Occupational and environmental lung diseases (34 papers), Pulmonary Hypertension Research and Treatments (32 papers), Neonatal Respiratory Health Research (31 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (31 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (38.2k citations), Physiology (7.7k citations), Rheumatology (2.5k citations), Cancer Research (2.0k citations) and Pathology and Forensic Medicine (2.2k citations). Moisés Selman has collaborated with scholars based in Mexico, United States and United Kingdom. Frequent co-authors include Annie Pardo, Talmadge E. King, Miguel Gaxiola, Ganesh Raghu, Naftali Kaminski, Mayra Edith Mejía, Carina Becerril, Remedios Ramı́rez, Carlos Ramos and Luca Richeldi. Their work appears in journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal, American Journal of Physiology-Lung Cellular and Molecular Physiology, European Respiratory Journal and American Journal of Respiratory Cell and Molecular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.